Introduction
The gastrointestinal epithelium is one of the most dynamic tissues in the adult organs. Renewal of the gut epithelium is characterized by a rapid turnover, requiring 3-8 days for complete replacement of the epithelium, and depends on several critical cellular processes, including cell proliferation within the epithelial crypts, differentiation of transit-amplifying cells into mature epithelial enterocytes, and cellular elimination owing to apoptosis and exfoliation. These processes are tightly regulated by a number of homeostatic mechanisms, among which TGF-b plays a major role by controlling the relative rates of proliferation and elimination of epithelial cells (Babyatsky and Podolsky, 1991; Ko et al., 1997) . TGF-b exerts its biological effects through a cell surface receptor complex, the TGF-b type I and type II receptors TbRI and TbRII. Upon ligand binding, TbRII phosphorylates TbRI, which subsequently phosphorylates Smad2 and Smad3. Phosphorylated Smad2 and Smad3 form a heteromeric complex with Smad4, translocate into the nucleus, and regulate the transcription of target genes (Heldin et al., 1997; Massague, 1998) , including Id (inhibitor of differentiation or inhibitor of DNA-binding) genes.
The inhibitor of differentiation (Id) proteins are a family of helix-loop-helix (HLH) proteins, which lack the basic DNA-binding domain that is characteristic of other members of this superfamily. Ids function in a dominant-negative manner by binding and sequestering basic HLH (bHLH) transcription factors, thereby blocking the binding of bHLH proteins to DNA (Norton, 2000) . Four mammalian Ids, Id1, Id2, Id3 and Id4, have been identified, which are expressed in undifferentiated and proliferating cells (Hasskarl and Munger, 2002) . Through binding bHLH proteins, Id proteins regulate a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis and neoplastic transformation.
Hypoxia-inducible factor HIF-1, a bHLH protein, was initially identified as a transcription factor that regulates erythropoietin gene expression in response to anemia or hypoxia (Semenza et al., 1991) . HIF-1 is a heterodimeric transcription factor consisting of an oxygen-sensitive a-subunit and a constitutive b-subunit, with apparent molecular masses of 120-130 and 91-94 kDa, respectively (Wang and Semenza, 1995) . Nuclear sequence analysis revealed that both subunits contain bHLH and PAS domains. The bHLH domain mediates dimerization and DNA binding in a large number of transcription factors, and the PAS domain provides an additional dimerization motif (Semenza, 1999) . Three a-subunits, HIF-1a, HIF-2a and HIF-3a, have been identified, all of which can dimerize with HIF-1b (or ARNT, aryl hydrocarbon receptor nuclear translocator), ARNT2 or ARNT3 (Semenza, 1999) . The heterodimeric complex constitutes the transcription factor HIF, which binds the hypoxia response element containing the consensus sequence 5 0 -RCGTG-3 0 to regulate the transcription of least 70 effector genes (Wenger et al., 2005) . The HIFa subunits differ in expression profiles. HIF-1a is expressed ubiquitously, whereas HIF-2a expression is restricted to the endothelium, kidney, heart, lungs and small intestine (Gordan et al., 2007) . HIF-1-and HIF-2-ab heterodimers function as transcriptional activators of oxygen-regulated target genes, whereas the role of HIF-3a is less clear, and a short splicing form of HIF-3a functions as a transcriptional repressor (Semenza, 1999; Wenger, 2002) .
Transforming growth factor-b (TGF-b) has been shown to inhibit Id1, Id2 and Id3 expression in several cell lines (Lasorella et al., 2000; Ling et al., 2002) . Repression of these three Id genes constitutes a TGF-b cytostatic program shared by human epithelial cell lines of different tissue origins (Kang et al., 2003) . In this study, we used affymetrix oligonucleotide microarrays to identify Id1, Id2 and Id3 as TGF-b targets in rat intestinal epithelial cells (RIE-1). Small interfering RNAs (siRNAs) were used to investigate the role of Id proteins in TGF-b-induced apoptosis. We report here for the first time that knockdown of Id1 and Id2 caused apoptosis in RIE-1 cells, whereas overexpression of Id2 blocked TGF-b-induced apoptosis. As Id proteins are generally believed to act as dominantnegative inhibitors of bHLH transcription factor activity, we used TranSignal Protein/DNA arrays to identify bHLH transcription factors that were regulated by TGF-b. We found that TGF-b activated HIF-1 and that overexpression of Id2 blocked this effect. Furthermore, knockdown of HIF-1 blocked TGF-b-induced apoptosis. Thus, we have identified HIF-1 as a novel mediator downstream of Id2 in the pathway of TGF-binduced apoptosis.
Results
TGF-b induces apoptosis in RIE-1 cells, which is Smad3-dependent Earlier, we have shown that cellular response to TGF-binduced apoptosis is dependent on the relative activities of Smad3 and Akt (Conery et al., 2004) . RIE-1 cells express low levels of Smad3 and are relatively resistant to TGF-b-induced apoptosis when maintained in normal growth medium with 5% serum. However, Akt activity is reduced when RIE-1 cells are maintained at low serum concentrations (0.5%), and apoptosis was induced when TGF-b was added to such cells (Figure 1 ). Conversely, a robust apoptotic response was observed in TGF-b-treated RIE-1/Smad3 cells, which express a higher level of Smad3. Furthermore, no apoptosis was detected in RIE-1 cells that express a dominant-negative form of Smad3 (RIE-1/Smad3DSSVS). These data indicate that Smad3 is the key mediator in apoptosis induction by TGF-b.
TGF-b represses Id expression
A genomic approach was used to compare gene expression profiles of RIE-1 and RIE-1/Smad3 cells with and without TGF-b treatment as described earlier (Cao et al., 2007) . Gene expression profiles were examined using affymetrix oligonucleotide microarrays for the rat (RG-U34A, B and C), which include approximately 26 000 rat probe sets with 7000 known genes and 19 000 ESTs. The microarray analyses revealed that TGF-b treatment decreased the abundance of mRNAs corresponding to Id1, Id2 and Id3 in RIE-1 cells and RIE-1/Smad3 cells. Downregulation of Ids by TGF-b was observed with two probe sets and was consistently observed in three independent experiments (Figure 2a) . To validate the results of the microarray analyses, we examined the expression of Id mRNA by real-time PCR as shown in Figure 2b . Consistent with Figure 3a) and western blotting ( Figure 3b ). Our results show that Id siRNAs specifically knocked down respective Id gene expression compared with nonspecific siRNA. Furthermore, the apoptotic effects of Id1 and Id2 siRNAs were comparable with that of TGF-b in RIE-1 cells ( Figure 3c top and middle panels). Id2 siRNA consistently induced greater apoptosis than did Id1 siRNA, whereas Id3 siRNA did not induce apoptosis, compared with nonspecific siRNA control. Similar effects of Id1 and Id2 siRNAs were observed in RIE-1/Smad3 cells ( Figure 3c ). The observation that knockdown of Id1 and Id2 induces apoptosis in RIE-1 and RIE-1/Smad3 suggests that downregulation of Id expression by TGF-b is sufficient to induce apoptosis in RIE cells.
Id2 repression by TGF-b is Smad3-dependent
The knockdown assay using Id siRNA revealed differential roles of Id1, Id2 and Id3 in apoptosis induction ( Figure 3 ), and knockdown of Id2 induced greater apoptosis in both RIE-1 and RIE-1/Smad3 cells. Therefore, we focused our analyses on Id2. Smad These results indicate that downregulation of Id2 is necessary for TGF-b-induced apoptosis in gut epithelial cells.
TGF-b activates HIF-1
Id2 is a dominant-negative inhibitor of the bHLH transcription factor, dimerizing with bHLH proteins to prevent DNA binding by such factors. This property of Ids suggests that TGF-b should regulate the activity of bHLH transcription factors. To test this prediction, we undertook a proteomic approach using the TranSignal Protein/DNA Arrays I, II and III to evaluate the effects Table 1 ). Particularly to our interest, we observed a significant increase in HIF-1 binding (about threefold) in nuclear extracts of TGF-btreated RIE-1/RK5 cells, compared with the vehicle control extracts. Moreover, we observed no increase in HIF-1-binding activity when RIE-1/Id2 cells were treated with TGF-b (Figure 6a ). Electrophoretic mobility shift assay (EMSA) was performed to validate the result of the transcription factor arrays. An increase in HIF-1 DNA binding was observed in nuclear extracts of RIE-1/RK5 cells treated with TGF-b at 5 h, compared with vehicle control (Figure 6b ). However, RIE-1/Id2 cells did not show increased HIF-1-binding activity in the presence of TGF-b. These results were confirmed by the DNA precipitation assay (Supplementary Figure 1) . The HIF-1 complexes on EMSA were confirmed by supershift with HIF-1b antibody or by competition with cold DNA probe. Our results suggest that TGF-b activates HIF-1 by a mechanism that requires downregulation of Id2.
HIF-1 mediates TGF-b-induced apoptosis
Our data are consistent with the hypothesis that TGF-b downregulates Ids, resulting in the activation of HIF-1. HIF-1 is a well-characterized bHLH transcription factor complex that is composed of a heterodimer of two bHLH proteins, the rate-limiting factor HIF-1a and the constitutively expressed HIF-1b. HIF-1 is activated by hypoxia and regulates hypoxia-driven gene expression. It is involved in a broad spectrum of biological functions, including apoptosis. These observations suggest that Id-dependent activation of HIF-1 may play a role in TGF-b-mediated apoptosis. This hypothesis predicts that knockdown of HIF-1 should block TGF-bmediated apoptosis. To test this prediction, we used siRNA knockdown of HIF-1a, the rate-limiting component of the HIF-1 complex. RIE-1/Smad3 were used, as these cells have a more robust response to TGF-b and provide a greater dynamic range to evaluate the effects of HIF-1 knockdown on TGF-b-mediated apoptosis.
As shown in Figure 7a , HIF-1a siRNA knocked down HIF-1a mRNA expression in the presence and absence of TGF-b. Furthermore, HIF-1a siRNA blocked TGF-b-mediated apoptosis (Figures 7b and c) . These observations indicate that HIF-1a is required for TGFb-induced apoptosis, which is consistent with the hypothesis that TGF-b induces apoptosis by downregulation of Ids, leading to activation of HIF-1, which induces apoptosis.
Discussion
Earlier, we have shown that Smad3 plays an essential role in TGF-b-induced apoptosis (Conery et al., 2004) .
To gain further insights into the TGF-b/Smad3-mediated apoptotic pathway in gut epithelial cells, we used a genomic approach to examine potential target genes involved in apoptosis. We found that the inhibitors of differentiation, Id1, Id2 and Id3, were downregulated by TGF-b. Knockdown of Id1 and Id2 led to apoptosis induction, and overexpression of Id2 inhibited TGF-b-induced apoptosis. Furthermore, using Protein/DNA array, we found that the transcription factor HIF-1 was activated by TGF-b and that knockdown of HIF-1 inhibited TGF-b-induced apoptosis. Therefore, we have identified HIF-1 as a novel mediator in TGF-b/Smad3-induced apoptosis. The profound cytostatic effect that TGF-b exerts on epithelial cells is of particular interest because of its role in tissue homeostasis and because of the importance that its disruption has in cancer (Gold, 1999; Massague et al., 2000) . Genome-wide transcriptional profiling of human epithelial cells using skin keratinocytes, lung epithelial cells and mammary epithelial cells revealed that repression of Ids is a general feature of the TGF-b cytostatic program (Kang et al., 2003) , in which TGF-b enforces homeostasis of epithelia by activating processes such as cell cycle arrest and apoptosis. The present studies focus mostly on the role of Id repression by TGF-b in cell growth suppression, differentiation and epithelial-mesenchymal transdifferentiation (Siegel et al., 2003; Kondo et al., 2004; Kowanetz et al., 2004) . However, the role of Id repression in TGF-b-mediated apoptosis induction has not been addressed earlier. 
Id2 in TGF-b-induced apoptosis Y Cao et al
The Id family proteins function as negative regulators of cell differentiation and as positive regulators of G1 cell cycle control (Zebedee and Hara, 2001; Yokota and Mori, 2002; Sikder et al., 2003) . Id proteins also drive apoptosis when ectopically overexpressed. However, the proapoptotic properties of Id proteins have been reported mostly in cell lines and primary cell models other than epithelial cells, such as fibroblasts (Nakajima et al., 1998; Norton and Atherton, 1998) , myeloid progenitors and osteosarcoma cells (Florio et al., 1998) , cardiac myocytes (Tanaka et al., 1998) , astrocytes (Andres-Barquin et al., 1997) and thymocytes (Kim et al., 1999) . There has been a report using constitutively expressed Id1 in mammary epithelial cell cultures showing that Id1 stimulated proliferation in sparse cultures but induced apoptosis in dense cultures (Parrinello et al., 2001 ). We did not observe apoptosis induction in our study using gut epithelial cell models by overexpression of Id2 protein. These suggest that the proapoptotic properties of Id2 are cell-type specific, as most of the reports limit themselves to cells other than those of epithelial origins. Instead, overexpression of Id2 protein inhibited TGF-b-induced apoptosis, which indicates that repression of Id2 is necessary for apoptosis induction by TGF-b. Furthermore, the observation that Id2 knockdown promotes apoptosis indicates that repression of Ids is sufficient to induce an apoptotic response in RIE cells.
As a member of the HLH family lacking a basic domain, Id proteins inhibit other bHLH proteins by forming dimers with bHLH proteins, which are mostly transcription factors. To investigate these transcription factors downstream of Id proteins regulated by TGF-b for the apoptosis induction, we screened 244 transcription factors simultaneously using transcription factor arrays under TGF-b treatment in RIE-1/RK5 cells. Multiple transcription factors were activated by TGF-b (Supplementary Table 1 ). Most notably, a bHLH protein, HIF-1, was significantly activated, which is consistent with the earlier report that TGF-b enhanced both AP-1 and HIF-1 DNA-binding activities to increase vascular endothelial growth factor expression (Shih and Claffey, 2001 ). Thus, we have identified HIF-1 as a target of TGF-b downstream of Id2. Furthermore, Id2 physically interacts with HIF-1 as shown by the immunoprecipitation assay (Supplement Figure 2) , suggesting that Id2-negative regulates HIF-1 activity. Furthermore, to study the role of HIF-1 in TGF-binduced apoptosis in RIEs, we used siRNA to knockdown HIF-1a gene expression, the inducible subunit of HIF-1, and showed that knockdown of HIF-1a inhibited TGF-b-induced apoptosis, suggesting that HIF-1a mediates TGF-b-induced apoptosis at least partially. We speculate that, in addition to HIF-1a, other isoforms of HIF may also be involved in TGF-binduced apoptosis. Our model is a normal physiological response by which TGF-b induces apoptosis through repression of Id2 and activation of HIF-1. However, in hypoxia condition, Id1 and Id2 upregulated by HIF-1 could play a significant role in dedifferentiation of hypoxic neuroblastoma cells, which could lead to less mature and more aggressive tumors (Lofstedt et al., 2004; Nemetski and Gardner, 2007) . In contrast, in a human breast cancer cell model, Id1 enhances HIF-1a protein stability, nuclear localization and activity (Kim et al., 2007) . These conflicting observations may be attributed to different cell models and hypoxia conditions used. Therefore, further studies are needed to determine the molecular mechanisms of the cross talk between Id and (a) Nuclear extracts of RIE-1/RK5 and RIE-1/Id2 (clone #3) were analysed using TranSignal Protein/DNA Arrays I, II and III, which include consensus-binding sequences for profiling 54, 96 and 94 transcription factors, respectively. The marked spots were HIF-1. (b) Nuclear extracts of RIE-1/RK5 and RIE-1/Id2#3 were analysed using electrophoretic mobility shift assay (EMSA). The nuclear extracts were incubated with labeled HIF-1 DNA probe, anti-HIF-1b antibody, or an unlabeled competitor DNA as indicated. The mixture was subjected to 6% DNA retardation gel electrophoresis. Id2 in TGF-b-induced apoptosis Y Cao et al HIF-1 in normoxia and hypoxia conditions, which may play a critical role in physiological and pathological processes.
In conclusion, we have identified Id2 as an important downstream target of TGF-b/Smad3-induced apoptosis in intestinal epithelial cells. We have shown that downregulation of Id2 is both necessary and sufficient for apoptosis in RIE cells. Furthermore, we have determined that activation of HIF-1 accounts, at least in part, for the Id2-dependent apoptotic effects of TGFb. The TGF-b/Smad signaling pathway has been shown to interact with HIF-1a to regulate expression of erythropoietin, vascular endothelial growth factor and endoglin (Sanchez-Elsner et al., 2001 , 2002 . Our study on the role of HIF-1 in TGF-b-induced apoptosis suggests a novel cross talk between TGF-b and HIF-1 in the regulation of apoptosis to control the turnover of gut epithelial cells and to prevent the development of gut diseases.
Materials and methods

Cell lines
Rat intestinal epithelial cells, RIE-1, were maintained in Dulbecco's modified Eagle's medium (DMEM, Mediatech Inc., Herndon, VA, USA) supplemented with 5% dialysed fetal bovine serum (dFBS, Invitrogen Co., Carlsbad, CA, USA). The RIE-1/Smad3 stable cell line was generated by infecting RIE-1 cells with a retrovirus pBabe that encodes the human Smad3 gene (Conery et al., 2004) , and RIE-1/pBabe as a vector control. The RIE-1/Smad3DSSVS stable cell line was generated by infecting RIE-1 cells with the retrovirus pLPCX that encodes a dominant-negative human Smad3 gene with the C-terminal deletion of SSVS (Choy et al., 2000) and RIE-1/ LPCX as a vector control. These cells were maintained in DMEM supplemented with 5% dFBS and 5 mg/ml of puromycin (Calbiochem-Novabiochem Co., San Diego, CA, USA). RIE-1/Id2 and RIE-1/S3/Id2 (RIE-1/Smad3/Id2) stable cell lines were generated by co-transfecting RK5-rat Id2 plasmid and pREP4 (contains hygromycin B-resistant gene), and were selected under 200 mg/ml of hygromycin B for RIE-1/ Id2 cells, 200 mg/ml of hygromycin B and 5 mg/ml of puromycin for RIE-1/S3/Id2 cells. RIE-1/RK5 and RIE-1/S3/RK5 served as vector controls, respectively. Cells were grown in 5% CO 2 atmosphere at 37 1C with 95% humidity.
Western blotting
Cultured cells were lysed in 1 Â cell lysis buffer (Cell Signaling Technology Inc., Danvers, MA, USA). Protein concentrations of cell lysates were quantified using a protein assay dye (BioRad Laboratories, Hercules, CA, USA). Western blotting was performed as described earlier (Nguyen et al., 2006; Cao et al., 2007) . Anti-Id antibodies were from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; anti-Flag and anti-b-actin antibodies were from Sigma-Aldrich Inc., St Louis, MO, USA; anti-Smad3 was from Invitrogen Co.; and anti-HIF-1a antibody was from R&D Systems (Minneapolis, MN, USA). Horseradish peroxidase-conjugated goat anti-rabbit and antimouse antibodies were from Bio-Rad Laboratories.
Apoptosis assays DNA fragmentation was quantified by the cell death detection ELISA assay (Roche Molecular Biochemicals, Indianapolis, IN, USA) according to the manufacturer's instructions as described earlier (Cao et al., 2007) . Apoptotic cells were stained with Annexin V-FITC and propidium iodide using the BD ApoAlert Annexin V-FITC Apoptosis kit (BD Bioscience, San Jose, CA, USA). Cells were analysed by flow cytometry, and cells stained only with Annexin V were identified as apoptotic cells as described earlier .
Microarray analysis
Microarray analysis was performed as described earlier (Cao et al., 2007) . Briefly, confluent RIE-1 and RIE-1/Smad3 cells were incubated in DMEM supplemented with 5% dFBS for 24 h and then in serum-free DMEM for 48 h. Cells were trypsinized and split into two 100-mm tissue culture plates. In the presence of 2 mmol/l thymidine, cells were maintained in DMEM supplemented with 5% dFBS for 16 h and then treated with or without 120 pmol/l of TGF-b1 (R&D Systems) for 6 h. The University of Texas Medical Branch Genomics Core Facility carried out RNA extraction, labeling, hybridization and scanning.
Real-time quantitative PCR
Real-time quantitative PCR was described earlier (Nguyen et al., 2006; Cao et al., 2007) . For detecting rat Id1, Id2 and Id3 mRNA transcripts, the following primers and probes designed from rat cDNA sequences (synthesized by Applied Biosystems, Foster City, CA, USA) were used: Id1 forward primer 5 0 -ctacgacatgaacggctgctac-3 0 , reverse primer 5 0 -gcgg ttctgaggcagggt-3 0 , and probe FAM (6-carboxyfluorescein)-5 0 -cacgcctcaaggagctggtgcc-3 0 -TAMRA (6-carboxy-tetramethylrhodamine); Id2 forward primer 5 0 -ggaccacagcttgggcat-3 0 , reverse primer 5 0 -tagagcagactcatcgggtcg-3 0 , and probe FAM (6-carboxyfluorescein)-5 0 -tcccggagcaaaaccccggt-3 0 -TAMRA (6-carboxy-tetramethylrhodamine); Id3 forward primer 5 0 -ctcagcttagccaggtggaaa-3 0 , reverse primer 5 0 -tctgccagaaccactt gaagg-3 0 , and probe FAM (6-carboxyfluorescein)-5 0 -ctgcagcgtgt catagactacatcctc-3 0 -TAMRA (6-carboxy-tetramethylrhodamine). For detecting the rat b-actin mRNA transcripts, the following primers and probe were used: forward primer 5 0 -cgtgaaaagatgacccagatca-3 0 (locating in exon 3), reverse primer 5 0 -cacagcctggatggctacgt-3 0 (locating in exon 4), and probe 6 FAM-5 0 -tgagaccttcaacaccccagccatg-3 0 -TAMRA (spanning exons 3 and 4).
Id and HIF-1a gene silencing Rat Id1 siRNA (L-080165-01), Id2 siRNA (M-080063-00), Id3 siRNA (L-080095-01), HIF-1a siRNA (L-091718-00, the siGENOME SMARTpool reagents from Dharmacon Inc. (Thermo Scientific-Dharmacon Inc., Chicago, IL, USA)) and the transfection reagent DharmaFECT 3 (Dharmacon Inc.) were used according to the manufacturer's instructions, as described earlier (Cao et al., 2007) . Scrambled siRNA (D-001206-13, Dharmacon Inc.) was used as a nonspecific siRNA control.
Transcription factor array
TranSignal Protein/DNA arrays I, II and III were obtained from Panomics Inc., Fremont, CA, USA. Biotin-labeled DNA-binding oligonucleotides (TranSignal probe mix) were incubated with 25 mg of nuclear extracts (prepared using nuclear and cytoplasmic extraction reagents, Pierce Biotechnology Inc. (Thermo Scientific-Pierce Biotechnology Inc., Rockford, IL, USA)) for 30 min to allow the formation of protein/DNA (or transcription factor/DNA) complexes. The protein/DNA complexes were then separated from the free probes by column chromatography. The probes present in the complexes were eluted and hybridized to the TranSignal Array Id2 in TGF-b-induced apoptosis Y Cao et al membrane overnight at 42 1C. Membranes were incubated with horseradish peroxidase-labeled streptavidin followed by the addition of chemiluminescence substrate. Signals were obtained after exposure to an X-ray film. Kodak 1D was used for quantification of the signals. Signals were normalized to untreated controls for each cell line, and any spots with X1.5-fold increase or decrease were considered significant.
Electrophoretic mobility shift assay Electrophoretic mobility shift assay was performed using the HIF-1 probe generated from biotinylated oligonucleotides containing HIF-1-binding element synthesized as 5 0 -CACA GTGCATACGTGGGCTTCCACA-3 0 and annealed with unbiotinylated complementary oligonucleotides as 5 0 -TGTGG AAGCCCACGTATGCACTGTG-3 0 (Integrated DNA Technologies, Coralville, IA, USA) (Levy et al., 1995) . The HIF-1 probe was incubated with 5 mg of nuclear extracts. Excess unlabeled competitor oligonucleotide was added to the reaction mixture when required. The protein/DNA complexes were separated on 6% non-denaturing polyacrylamide DNA retardation gel (Invitrogen). The gel was transferred to a nylon membrane (Ambion, Applied Biosystems-Ambion Inc., Austin, TX, USA) and detected using streptavidin-horseradish peroxidase and a chemiluminescent substrate by exposure to an X-ray film. The shifted bands corresponding to the protein/ DNA complexes were visualized relative to the unbound DNA. For supershift assay, 2 mg anti-HIF-1b antibody (Novus Biologicals, Littleton, CO, USA) was incubated with nuclear lysate for 45 min at room temperature before the addition of the biotinylated HIF-1 probe.
DNA precipitation assay DNA precipitation assay was performed as described (Alliston et al., 2005) . Biotinylated 5 0 oligonucleotides containing the HIF-1-binding element were synthesized and annealed with unbiotinylated complementary oligonucleotides to generate wild-type probe 5 0 -AGCTTGCCCTACGTGCTGTCTAG A-3 0 . A mutant probe 5 0 -AGCTTGCCCTAAAAGCTGTCT AGA-3 0 was also synthesized. Briefly, immobilization of biotinylated oligonucleotide probes and absorption of nuclear extracts were carried out using Dynabeads (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. After extensive washing, DNA-bound proteins were subjected to SDS-polyacrylamide gel electrophoresis, followed by western blotting. In parallel, the nuclear lysates were immunoblotted to show the protein levels.
Immunoprecipitation
Nuclear lysates were prepared from RIE-1/RK5 or RIE-1/Id2 cells using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce, Rockford, IL, USA). FLAG-tagged proteins were immunoprecipitated from nuclear lysates with Anti-FLAG (M2; Sigma-Aldrich) using magnetic Dynabeads Protein G (Invitrogen).
Statistical analysis
Data were expressed as means ± s.e.m. Differences between groups were analysed by analysis of variance with TukeyKramer multiple comparisons test, and Po0.05 is considered significant. All experiments were repeated at least twice and similar results were obtained.
